Rigel Pharmaceuticals, Inc.

350 articles with Rigel Pharmaceuticals, Inc.

• Rigel Pharmaceuticals, Inc. Describes Role Of UHRF1, A Ubiquitin Ligase, In Tumor Growth

  11/28/2005

• Rigel Pharmaceuticals, Inc. Announces Presentation Of Phase I Data On R406/788 At The American College of Rheumatology Annual Meeting

  11/14/2005

• Rigel Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences

  11/9/2005

• Rigel Pharmaceuticals, Inc. Announces Third Quarter 2005 Financial Results

  11/8/2005

• Rigel Pharmaceuticals, Inc. Announces Publications Highlighting Two New Screening Mechanisms For Ubiquitin Ligase Inhibitors

  11/3/2005

• Rigel Pharmaceuticals, Inc. Announces Presentations At American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting

  10/27/2005

• Serono International S.A. Signs Cancer Drug Deal With Rigel Pharmaceuticals, Inc., Eyes More

  10/25/2005

• Rigel Announces Second Quarter 2005 Financial Results

  8/3/2005

• Semi-Annual Changes To The NASDAQ Biotechnology Index

  11/15/2004

• Centient Investor Release: Biggest Biotech Winners And Losers During Q3

  10/13/2004